Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder.

Post RM, Leverich GS, Kupka R, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA.

Compr Psychiatry. 2016 Apr;66:146-56. doi: 10.1016/j.comppsych.2016.01.009. Epub 2016 Jan 26.

PMID:
26995248
2.

Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.

Shansis FM, Reche M, Capp E.

J Affect Disord. 2016 Jun;197:1-7. doi: 10.1016/j.jad.2016.02.064. Epub 2016 Mar 3.

PMID:
26950019
3.

An exploratory study of responses to low-dose lithium in African Americans and Hispanics.

Gonzalez Arnold J, Salcedo S, Ketter TA, Calabrese JR, Rabideau DJ, Nierenberg AA, Bazan M, Leon AC, Friedman ES, Iosifescu D, Sylvia LG, Ostacher M, Thase M, Reilly-Harrington NA, Bowden CL.

J Affect Disord. 2015 Jun 1;178:224-8. doi: 10.1016/j.jad.2015.02.035. Epub 2015 Mar 14.

4.

Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.

Zeinoddini A, Sorayani M, Hassanzadeh E, Arbabi M, Farokhnia M, Salimi S, Ghaleiha A, Akhondzadeh S.

Depress Anxiety. 2015 Mar;32(3):167-73. doi: 10.1002/da.22340. Epub 2015 Jan 23.

PMID:
25620378
5.

[Treatment-resistant depression: state of the art. Part I. Nosography and clinic].

Luchini F, Cosentino L, Pensabene L, Mauri M, Lattanzi L.

Riv Psichiatr. 2014 Sep-Oct;49(5):207-16. doi: 10.1708/1668.18260. Review. Italian.

PMID:
25424334
6.

Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.

Bobo WV, Reilly-Harrington NA, Ketter TA, Brody BD, Kinrys G, Kemp DE, Shelton RC, McElroy SL, Sylvia LG, Kocsis JH, McInnis MG, Friedman ES, Singh V, Tohen M, Bowden CL, Deckersbach T, Calabrese JR, Thase ME, Nierenberg AA, Rabideau DJ, Schoenfeld DA, Faraone SV, Kamali M.

J Affect Disord. 2014 Jun;161:30-5. doi: 10.1016/j.jad.2014.02.046. Epub 2014 Mar 13.

7.

Combination antidepressant therapy for major depressive disorder: speed and probability of remission.

Stewart JW, McGrath PJ, Blondeau C, Deliyannides DA, Hellerstein D, Norris S, Amat J, Pilowsky DJ, Tessier P, Laberge L, O'Shea D, Chen Y, Withers A, Bergeron R, Blier P.

J Psychiatr Res. 2014 May;52:7-14. doi: 10.1016/j.jpsychires.2013.12.001. Epub 2013 Dec 17.

PMID:
24485847
8.

Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients: a follow-up study.

Dell'Osso B, Dobrea C, Arici C, Benatti B, Ferrucci R, Vergari M, Priori A, Altamura AC.

CNS Spectr. 2014 Aug;19(4):347-54. doi: 10.1017/S1092852913000497. Epub 2013 Aug 20.

PMID:
23962405
9.

Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes: a naturalistic study.

Muti M, Del Grande C, Musetti L, Marazziti D, Pergentini I, Corsi M, Turri M, Umberto Corsini G, Dell'Osso L.

Int Clin Psychopharmacol. 2013 Nov;28(6):305-11. doi: 10.1097/YIC.0b013e3283642348.

PMID:
23873290
10.

Higher pretreatment 5-HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: a naturalistic treatment pilot PET study.

Lan MJ, Hesselgrave N, Ciarleglio A, Ogden RT, Sullivan GM, Mann JJ, Parsey RV.

Synapse. 2013 Nov;67(11):773-8. doi: 10.1002/syn.21684. Epub 2013 Jun 17.

11.
12.

Post-acute effectiveness of lithium in pediatric bipolar I disorder.

Findling RL, Kafantaris V, Pavuluri M, McNamara NK, Frazier JA, Sikich L, Kowatch R, Rowles BM, Clemons TE, Taylor-Zapata P.

J Child Adolesc Psychopharmacol. 2013 Mar;23(2):80-90. doi: 10.1089/cap.2012.0063.

13.

Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.

Nierenberg AA, Friedman ES, Bowden CL, Sylvia LG, Thase ME, Ketter T, Ostacher MJ, Leon AC, Reilly-Harrington N, Iosifescu DV, Pencina M, Severe JB, Calabrese JR.

Am J Psychiatry. 2013 Jan;170(1):102-10. doi: 10.1176/appi.ajp.2012.12060751.

PMID:
23288387
14.

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.

Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.

BMC Psychiatry. 2012 Dec 17;12:228. doi: 10.1186/1471-244X-12-228.

15.

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial.

Berk M, Dean OM, Cotton SM, Gama CS, Kapczinski F, Fernandes B, Kohlmann K, Jeavons S, Hewitt K, Moss K, Allwang C, Schapkaitz I, Cobb H, Bush AI, Dodd S, Malhi GS.

BMC Med. 2012 Aug 14;10:91. doi: 10.1186/1741-7015-10-91.

16.

A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression.

Goldberg JF.

J Affect Disord. 2013 Jan 10;144(1-2):176-8. doi: 10.1016/j.jad.2012.04.037. Epub 2012 Aug 1.

PMID:
22858262
17.

Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.

Alevizos B, Alevizos E, Leonardou A, Zervas I.

Psychiatriki. 2012 Apr-Jun;23(2):143-8.

PMID:
22796912
18.

Four hygienic-dietary recommendations as add-on treatment in depression: a randomized-controlled trial.

García-Toro M, Ibarra O, Gili M, Serrano MJ, Oliván B, Vicens E, Roca M.

J Affect Disord. 2012 Oct;140(2):200-3. doi: 10.1016/j.jad.2012.03.031. Epub 2012 Apr 18.

PMID:
22516309
19.

Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients.

Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Rowe M, Kupka RW, Grunze H, Goodwin FK.

J Clin Psychiatry. 2012 Jul;73(7):924-30. doi: 10.4088/JCP.11m07396. Epub 2012 Mar 20.

PMID:
22480597
20.

Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder.

Perlis RH, Cusin C, Fava M.

Psychol Med. 2014 May;44(7):1361-7. doi: 10.1017/S0033291712000281. Epub 2012 Mar 15.

PMID:
22417535

Supplemental Content

Loading ...
Support Center